A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
for Advanced Breast Cancer
37 locations incl. Springdale
Sponsor: Stemline Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06638307·Phase 1·Recruiting·Listed Oct 2024
Sarah Cannon Research Institute at Florida Cancer Specialists
Clinical research site in Orlando, Florida
Part of Sarah Cannon Research Institute
As of July 2026, 9 paid clinical trials are recruiting at Sarah Cannon Research Institute at Florida Cancer Specialists in Orlando, Florida. Active studies at this site cover conditions such as Advanced Solid Tumor, Mesothelioma and Adenocarcinoma of Esophagus. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Sarah Cannon Research Institute at Florida Cancer Specialists (9)
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
for Mesothelioma
22 locations incl. Phoenix
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT05245500·Phase 1·Recruiting·Listed Feb 2022
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
for NSCLC Adenocarcinoma
15 locations incl. Santa Rosa
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18+
Code: NCT07277413·Phase 1·Recruiting·Listed Dec 2025
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
for Small-cell Lung Cancer
13 locations incl. Denver
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18+
Code: NCT07174583·Phase 1, Phase 2·Recruiting·Listed Sep 2025
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
for Colorectal Neoplasms
19 locations incl. Phoenix
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT06131840·Phase 1·Recruiting·Listed Nov 2023
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
for Advanced Solid Tumors
11 locations incl. Aurora
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All·Age: 18+
Code: NCT06384352·Phase 1·Recruiting·Listed Apr 2024
Study of XB010 in Subjects With Solid Tumors
for Locally Advanced or Metastatic Solid Tumors
16 locations incl. Irvine
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT06545331·Phase 1·Recruiting·Listed Aug 2024
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
for Advanced Solid Tumor
12 locations incl. Sacramento
Sponsor: DualityBio Inc.
Sex: All·Age: 18+
Code: NCT05785741·Phase 1, Phase 2·Recruiting·Listed Mar 2023
Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations
for Solid Tumors (Phase 1)
3 locations incl. Orlando
Sponsor: Adlai Nortye Biopharma Co., Ltd.
Sex: All·Age: 18+
Code: NCT07252479·Phase 1·Recruiting·Listed Nov 2025
More research sites in Orlando
- AdventHealth Orlando (60 trials)
- Arnold Palmer Hospital for Children (37 trials)
- Nemours Children's Hospital (37 trials)
- Orlando Health (31 trials)
- University of Central Florida (31 trials)
- Orlando Health Cancer Institute (30 trials)
- AdventHealth (28 trials)
- Advent Health (17 trials)
- Orlando Clinical Research Center (17 trials)
- Charter Research (11 trials)
Explore more
Paid clinical trials in Orlando, FL · Florida clinical trials